Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
- Status
- TERMINATED
- Phase
- NA
A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus in Refractory Testicular Germ Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults
- Status
- UNKNOWN
- Phase
- PHASE4
Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus in de Novo Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Rotating Pazopanib and Everolimus to Avoid Resistance
- Status
- COMPLETED
- Phase
- PHASE2